Alivus Life Sciences Ltd
ALIVUS
Company Profile
Business description
Alivus Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disorders, pain management, diabetes, urology, gastrointestinal disorders, and other therapeutic areas.
Contact
470, Cardinal Gracious Road
4th Floor, OIA House
Andheri (East)
MumbaiMH400 099
INDT: +91 2268297979
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
2,220
Stocks News & Analysis
stocks
3 global ‘buy the dip’ candidates with wide moats
Does recent share price weakness spell opportunity in these three high-quality companies? Our analysts think so.
stocks
What next for Nine Entertainment after Domain payout?
The media group has excelled in controlling what it can control. Now the focus shifts to capital deployment.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,110.60 | 30.10 | 0.33% |
| CAC 40 | 7,823.52 | 62.20 | 0.80% |
| DAX 40 | 23,703.65 | 70.70 | 0.30% |
| Dow JONES (US) | 46,108.00 | 617.08 | 1.36% |
| FTSE 100 | 9,297.58 | 72.19 | 0.78% |
| HKSE | 26,086.32 | 113.94 | -0.43% |
| NASDAQ | 22,043.07 | 157.01 | 0.72% |
| Nikkei 225 | 44,798.00 | 425.50 | 0.96% |
| NZX 50 Index | 13,265.56 | 36.41 | 0.28% |
| S&P 500 | 6,587.47 | 55.43 | 0.85% |
| S&P/ASX 200 | 8,842.90 | 29.10 | 0.33% |
| SSE Composite Index | 3,875.31 | 63.09 | 1.65% |